DA VOLTERRA MICROBIOTA PROTECTION (IDFF)
The status, timeline and source of this project. A free account opens every field.
Source: European Investment Bank (EIB)
DaVolterra is a french SME company looking to finance its clinical trials and regulatory work related to the validation and market introduction of a micro-encapsulated material that inhibits the deleterious action of antibiotics on the intestinal flora, including the deadly consequences such as Clostridium Difficile Infections (c-diff). Market launch expected for 2018/2019.
- Status
- Prospective
- Sector
- Hospital, Hotel, Manufacturing (Industrial), Government
- Location
- France
- Updated
- 19 Nov 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about DA VOLTERRA MICROBIOTA PROTECTION (IDFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | financed |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | DaVolterra is a french SME company looking to finance its clinical trials and regulatory work related to the validation and market introduction of a micro-encapsulated material that inhibits the deleterious action of antibiotics on the intestinal flora, including the deadly consequences such as Clostridium Difficile Infections (c-diff). Market launch expected for 2018/2019. |
Original sector | Services |
Budget |
Location
Country | France |
Source
Source reliability | High |
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Hospital, Hotel, Manufacturing (Industrial), Government |
Article published date | 2023-05-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
